会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Powdery composition for nasal administration
    • 用于鼻腔给药的粉状组合物
    • US06881423B2
    • 2005-04-19
    • US09125814
    • 1997-02-26
    • Masahiko DohiYoshihisa NishibeYuji MakinoTako Fujii
    • Masahiko DohiYoshihisa NishibeYuji MakinoTako Fujii
    • A61K9/00A61K9/50A61K9/14
    • A61K9/0043
    • A powdery composition for nasal administration, where (1) the composition contains (i) a drug, (ii) a water-absorbing and gel-forming base material such as hydroxyprophyl cellulose or hydroxpropylmethyl cellulose and (iii) a water-absorbing and water-insoluble base material such as crystalline cellulose or α-cellulose, (2) wherein the amount of water-absorbing and gel-forming base material is about 5-40 wt. % based on the total of the water-absorbing and gel-forming base material and the water-absorbing and water-insoluble base material, and (3) wherein the drug is unevenly dispersed more on/in the water-absorbing and water-insoluble base material than on/in the water-absorbing and gel-forming base material.
    • 一种用于鼻腔给药的粉末组合物,其中(1)组合物包含(i)药物,(ii)吸水和凝胶形成基材如羟丙基纤维素或羟丙基甲基纤维素和(iii)吸水和水 不溶性基材如结晶纤维素或α-纤维素,(2)其中吸水和凝胶形成基材的量为约5-40wt。 基于吸水和凝胶形成基材和吸水性和水不溶性基材的总量的%,和(3)其中药物不均匀地分散在吸水性和水不溶性的/ 基材比吸水和凝胶形成基材上/上。
    • 2. 发明授权
    • Powdery composition for nasal administration
    • 用于鼻腔给药的粉状组合物
    • US07731990B2
    • 2010-06-08
    • US10860058
    • 2004-06-04
    • Masahiko DohiYoshihisa NishibeYuji MakinoTako Fujii
    • Masahiko DohiYoshihisa NishibeYuji MakinoTako Fujii
    • A61K9/50A61K9/14
    • A61K9/0043
    • A powdery composition for nasal administration, where (1) the composition contains (i) a drug, (ii) a water-absorbing and gel-forming base material such as hydroxypropyl cellulose or hydroxypropylmethyl cellulose and (iii) a water-absorbing and water-insoluble base material such as crystalline cellulose or α-cellulose, (2) wherein the amount of the water-absorbing and gel-forming base material is about 5-40 wt % based on the total of the water-absorbing and gel-forming base material and the water-absorbing and water-insoluble base material, and (3) wherein the drug is unevenly dispersed more on/in the water-absorbing and water-insoluble base material than on/in the water-absorbing and gel-forming base material.
    • 一种用于鼻腔给药的粉末组合物,其中(1)组合物包含(i)药物,(ii)吸水和凝胶形成基材如羟丙基纤维素或羟丙基甲基纤维素和(iii)吸水和水 - 不溶性基材如结晶纤维素或α-纤维素,(2)其中吸水和凝胶形成基材的量相对于吸水和凝胶形成的总量为约5-40重量% 基材和吸水性和水不溶性基材,和(3)其中药物在吸水性和水不溶性基材中/吸水凝胶形成中的/不均匀分散 基材。